QUARTA, ERIDE
 Distribuzione geografica
Continente #
EU - Europa 581
NA - Nord America 325
AS - Asia 79
OC - Oceania 3
AF - Africa 2
SA - Sud America 2
Totale 992
Nazione #
US - Stati Uniti d'America 324
IT - Italia 202
IE - Irlanda 189
SE - Svezia 106
CN - Cina 51
AT - Austria 20
DE - Germania 20
NL - Olanda 14
SG - Singapore 11
FI - Finlandia 8
IN - India 8
FR - Francia 6
TR - Turchia 6
GB - Regno Unito 3
AR - Argentina 2
CZ - Repubblica Ceca 2
HK - Hong Kong 2
NZ - Nuova Zelanda 2
RO - Romania 2
RS - Serbia 2
RU - Federazione Russa 2
AU - Australia 1
BD - Bangladesh 1
BG - Bulgaria 1
CA - Canada 1
GH - Ghana 1
GR - Grecia 1
HR - Croazia 1
NG - Nigeria 1
PT - Portogallo 1
UA - Ucraina 1
Totale 992
Città #
Dublin 185
Chandler 97
Parma 59
Ann Arbor 38
Ashburn 36
Shanghai 29
Milan 19
Vienna 18
Bologna 16
Groningen 12
Princeton 12
Rome 12
Reggio Emilia 11
Seattle 11
Ardea 8
Beijing 7
Helsinki 7
Des Moines 6
Falls Church 6
Stockholm 6
West Jordan 6
Wilmington 6
Ferrara 5
Fremont 5
Montegaldella 5
Segrate 5
Strasbourg 5
Konyaalti 4
Los Angeles 4
Bremen 3
Chicago 3
Fairfield 3
Guangzhou 3
Pune 3
Auckland 2
Belgrade 2
Bergamo 2
Birmingham 2
Boardman 2
Brno 2
Brooklyn 2
Buenos Aires 2
Collecchio 2
Dearborn 2
Garden City 2
Grafing 2
Granarolo dell'Emilia e Viadagola 2
Hangzhou 2
Homburg 2
Hong Kong 2
Houston 2
Kocaeli 2
Lonato 2
Modena 2
Montelupone 2
New York 2
Nuremberg 2
Phoenix 2
Santa Teresa Di Riva 2
Syracuse 2
Turin 2
Woodbridge 2
Adelaide 1
Amsterdam 1
Bari 1
Baricella 1
Borås 1
Carpenedolo 1
Changsha 1
Chilly-mazarin 1
Delhi 1
Edinburgh 1
Frankfurt am Main 1
Hyderabad 1
Jiaxing 1
Kamampa 1
Miami 1
Neviano degli Arduini 1
New Delhi 1
Ottawa 1
Palermo 1
Pesaro 1
Piscataway 1
Pompiano 1
Rockville 1
Santa Clara 1
Sherpur 1
Sofia 1
Xiangfen 1
Zagreb 1
Totale 739
Nome #
Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats 131
Inhalable microparticles embedding calcium phosphate nanoparticles for heart targeting: The formulation experimental design 77
Consequences of not-shaking and shake-fire delays on the emitted dose of some commercial solution and suspension pressurized metered dose inhalers 73
Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction 69
Design and Characterization of Maltoheptaose-b-Polystyrene Nanoparticles, as a Potential New Nanocarrier for Oral Delivery of Tamoxifen 56
Development of inhalation powders containing lactic acid bacteria with antimicrobial activity against Pseudomonas aeruginosa 49
An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro 47
Nasal delivery as a strategy for the prevention and treatment of COVID-19 47
Orphan Designation and Cisplatin/Hyaluronan Complex in an Intracavitary Film for Malignant Mesothelioma 46
The Impact of Possible Misuses Conditions on in Vitro Performance of NEXThaler in Comparison with Ellipta Inhaler 43
Respicelltm: An innovative dissolution apparatus for inhaled products 39
Dry powder inhalation technology for heart targeting applied to calcium phosphate nanoparticles loaded with active substances 38
Glycyrrhizic acid and its hydrolyzed metabolite 18β-glycyrrhetinic acid as specific ligands for targeting nanosystems in the treatment of liver cancer 37
Understanding the importance of capsules in dry powder inhalers 35
Flurbiprofen sodium microparticles and soft pellets for nose-to-brain delivery: Serum and brain levels in rats after nasal insufflation 34
No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs 33
Nuove composizioni antivirali e loro utilizzo in terapia e nel trattamento di infezioni virali 31
Calcium phosphate nanoparticle precipitation by a continuous flow process: A design of an experiment approach 26
Inhalable Microparticles Embedding Biocompatible Magnetic Iron-Doped Hydroxyapatite Nanoparticles 24
Recent Patents on Nasal Vaccines Containing Nanoadjuvants 24
POWDER COMPOSITION BASED ON MICROPARTICLES EMBEDDING NANOPARTICLES FOR THE DELIVERY OF THERAPEUTIC/DIAGNOSTIC COMPOUNDS 21
Lung-to-Heart Nano-in-Micro Peptide Promotes Cardiac Recovery in a Pig Model of Chronic Heart Failure 17
Probing critical physical properties of lactose-polyethylene glycol microparticles in pulmonary delivery of chitosan nanoparticles 16
Novel Dry Hyaluronic Acid–Vancomycin Complex Powder for Inhalation, Useful in Pulmonary Infections Associated with Cystic Fibrosis 10
No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs (vol 631, 122478, 2023) 5
Totale 1.028
Categoria #
all - tutte 4.317
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.317


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202019 0 0 1 0 0 1 5 2 2 2 0 6
2020/2021117 5 1 1 6 11 20 25 11 15 8 12 2
2021/2022112 3 3 8 5 20 5 12 8 9 1 7 31
2022/2023430 36 49 19 33 27 43 30 35 129 11 9 9
2023/2024350 11 18 8 20 26 59 112 31 24 31 10 0
Totale 1.028